TASI 8030 · Insurance · MEDGULF
Cash Flow Statement
9M / Q3 2023Selected reported lines
SAR thousands| Reported line | Reported value | Source |
|---|---|---|
| Net cash from (used in) operating activities | (53090) | p. 10 ↗ |
| Net cash from (used in) investing activities | 146571 | p. 10 ↗ |
| Net cash from (used in) financing activities | (9190) | p. 10 ↗ |
| Cash and cash equivalents at the end of the period | 515222 | p. 10 ↗ |
| Income (loss) before zakat and income tax | 145560 | p. 10 ↗ |
| Depreciation and amortization | 11694 | p. 10 ↗ |
| Depreciation of right-of-use assets | 6723 | p. 10 ↗ |
| finance charges on lease liabilities | 401 | p. 10 ↗ |
| Net impairment loss on financial assets | 152 | p. 10 ↗ |
| Share of loss from associateNote 8 | 690 | p. 10 ↗ |